Dianabol(Methandrostenolone)Steroids Powder For Bodybuilding CAS:72-63-9

   Defining Methandrostenolone Powder: Core Chemical Identity

    ●Chemical Structure: Methandrostenolone belongs to the dihydrotestosterone (DHT) derivative family but is structurally modified. Key features include:

    ○1,2-Dehydrogenation: Introduction of a double bond between carbon atoms 1 and 2 (similar to the female hormone Estradiol) significantly increases its anabolic potency relative to its androgenic effects compared to testosterone.

    ○17α-Methylation: Addition of a methyl group (-CH3) at the 17th carbon position protects the molecule from rapid deactivation by the liver during first-pass metabolism, enabling oral bioavailability. This modification is also responsible for its significant hepatotoxicity.

    ●Physical Form: As a powder, Methandrostenolone typically appears as a fine white to off-white crystalline substance. Its particle size distribution can vary depending on synthesis and purification methods, impacting properties like solubility and flow characteristics.

    ●Solubility: Exhibits very low solubility in water. It demonstrates better solubility in organic solvents like ethanol, chloroform, or dimethyl sulfoxide (DMSO), a crucial factor in specific laboratory handling or potential formulation research.

    ●Purity & Potency: Pharmaceutical-grade powder represents the pure active pharmaceutical ingredient (API), free from binders, fillers, dyes, or coatings found in finished tablets. Theoretical potency is maximized per unit mass. However, illicitly sourced powder purity is highly variable and unverifiable without sophisticated analytical testing (HPLC, MS).

    ●Handling & Stability: Requires stringent handling protocols in a research setting:

    ○Stability: Degrades upon prolonged exposure to light, heat (>25°C), oxygen, and moisture. Requires storage in airtight, light-resistant containers under inert gas (e.g., argon) at controlled low temperatures (2-8°C) for long-term stability.

    ○Hygroscopicity: May absorb moisture from the air, leading to clumping, potential degradation, and inaccurate dosing.

    ○Safety: Strict laboratory safety practices (gloves, masks, fume hoods) are essential to prevent accidental inhalation or dermal absorption due to its potency and potential health hazards.

    ●Formulation Versatility (Theoretical): In controlled pharmaceutical development, the powder serves as the starting material for creating various dosage forms (oral tablets, sublingual troches, transdermal gels – though oral is predominant for this compound). Illicit use often involves hazardous and inaccurate "homebrewing" into capsules or liquids.

    Research into Methandrostenolone's mechanisms reveals pathways relevant to muscle physiology:

    1.Anabolic Stimulation: Binds strongly to androgen receptors (AR) within skeletal muscle tissue. This AR activation directly stimulates the synthesis of contractile proteins (actin, myosin) and other structural components, driving hypertrophy.

    2.Enhanced Protein Synthesis: Significantly upregulates the cellular machinery responsible for translating genetic code into new muscle proteins. This occurs via modulation of signaling pathways like mTOR.

    3.Nitrogen Retention: Promotes a highly positive nitrogen balance within muscle cells. Nitrogen is a fundamental component of amino acids (protein building blocks). Retaining more nitrogen creates a favorable internal environment for sustained muscle growth and repair.

    4.Glycogenolysis & Substrate Utilization: May increase glycogen breakdown in muscles and liver, potentially making more glucose available for energy during intense activity. It might also influence the utilization of fatty acids and amino acids for fuel, though effects are complex.

    5.Erythropoiesis Stimulation: Can increase red blood cell (RBC) production (erythropoiesis) by stimulating renal erythropoietin (EPO) release and possibly acting directly on bone marrow precursors. Elevated RBC count enhances blood oxygen-carrying capacity, potentially delaying fatigue.

    6.Central Nervous System (CNS) Effects: Exhibits mild glucocorticoid antagonism, potentially reducing the catabolic muscle breakdown associated with stress hormones like cortisol. May also induce mild euphoria and increased aggression ("roid rage"), indirectly impacting training intensity.

    Dosing raw powder is exceptionally hazardous due to the extreme difficulty in achieving accuracy without specialized analytical equipment. Microgram scales are insufficiently precise and prone to significant error. Theoretical dosages discussed in research literature for oral Methandrostenolone generally range:

    ●Research Threshold: Studies investigating effects often start at very low doses (e.g., 2-5 mg/day) to establish baseline responses.

    ●Common Range: Many studies examining performance or therapeutic effects historically utilized 15-30 mg per day, often split into 2-3 doses due to its relatively short half-life.

    ●High-Dose Research: Some investigations explored doses up to 50 mg or higher daily, invariably noting a dramatic increase in adverse effects without proportional benefits.

    ●Critical Warning: Attempting to "measure" powder doses using household tools or standard milligram scales is profoundly dangerous. Inaccurate dosing can lead to acute toxicity or chronic, severe health consequences. Pharmaceutical manufacturing uses highly controlled environments and precision equipment for formulation.

    ●Half-Life: Methandrostenolone has a relatively short half-life, estimated between 3.5 to 6 hours. This necessitates multiple daily doses (e.g., every 8-12 hours) to maintain stable blood levels when researched, contrasting with long-acting injectables. The active metabolites may linger longer.

    ●Cycle Duration (Research Contexts): Studies exploring the effects of 17α-methylated AAS like Methandrostenolone are typically limited in duration (e.g., 4-8 weeks) precisely because of the well-documented risk of hepatotoxicity with prolonged exposure. Longer durations exponentially increase liver strain and other adverse events.

    ●"Kickstarting": In historical athletic research contexts, its rapid onset of action (noticeable effects within days) made it a candidate for initiating cycles where longer-acting injectable compounds (like Testosterone Enanthate or Nandrolone) were used concurrently. The Methandrostenolone would provide immediate anabolic effects while waiting for the injectable ester to reach stable concentrations over weeks.

    Methandrostenolone, like all exogenous androgens, potently suppresses the body's natural production of testosterone via the Hypothalamic-Pituitary-Testicular Axis (HPTA):

    1.Suppression Mechanism: Elevated androgen levels signal the hypothalamus to reduce Gonadotropin-Releasing Hormone (GnRH) secretion. This reduces pituitary output of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). Without LH stimulation, the testes drastically reduce or cease testosterone production and spermatogenesis.

    2.PCT Imperative: Upon cessation of Methandrostenolone, the HPTA remains suppressed. Without intervention, recovery can be extremely slow (months) or sometimes incomplete, leading to persistent low testosterone symptoms (fatigue, depression, libido loss, muscle loss, fat gain). PCT is not optional; it's a critical physiological rescue process.

    3.PCT Agents (Research Focus):

    ○SERMs (Selective Estrogen Receptor Modulators):

    ◇Tamoxifen Citrate: Blocks estrogen receptors in the hypothalamus/pituitary, reducing the negative feedback from even low estrogen levels. This encourages increased GnRH, LH, and FSH release to restart testicular function. A common research protocol involves 20-40 mg/day for 4-6 weeks.

    ◇Clomiphene Citrate (Clomid): Similar mechanism to Tamoxifen but often considered slightly more potent for LH stimulation. Used at 25-50 mg/day for 4-6 weeks.

    ○Aromatase Inhibitors (AIs - Adjuncts, not core PCT): Drugs like Anastrozole or Letrozole block estrogen synthesis. While sometimes used during a cycle containing aromatizable compounds to manage estrogen, they are generally less effective than SERMs for stimulating HPTA recovery post-cycle. Their role in PCT is usually secondary or for managing estrogen rebound if SERMs cause it.

    ○hCG (Human Chorionic Gonadotropin - Priming): Mimics LH, directly stimulating the testes to produce testosterone during the cycle or immediately before PCT starts. This prevents testicular atrophy and can "prime" the testes to respond better to the LH surge induced by SERMs during PCT. Used short-term (e.g., 500-1000 IU EOD for 10 days) at the cycle's end, before starting SERMs. Not used throughout the entire PCT.

    4.PCT Timing: Initiation depends on the compound's half-life and metabolites. For Methandrostenolone alone, PCT typically starts 1-2 days after the last dose due to its short half-life. If combined with long esters, PCT starts weeks later.

    5.Complexity: PCT protocols are highly individualized and depend on the specific compounds used, dosages, cycle length, and individual response. There is no universal "one-size-fits-all" approach validated in controlled clinical settings for AAS cessation.

    Research overwhelmingly documents the substantial risks associated with Methandrostenolone use:

    ●Hepatotoxicity: The 17α-methyl group causes significant liver strain. Effects include:

    ○Elevated liver enzymes (AST, ALT)

    ○Hepatocyte damage, cholestasis (impaired bile flow)

    ○Hepatic peliosis (blood-filled cysts)

    ○Increased risk of hepatocellular adenoma/carcinoma with prolonged use.

    ●Cardiovascular: Negative impacts on cholesterol profiles (lowers HDL "good" cholesterol, raises LDL "bad" cholesterol), promotes hypertension, increases risk of left ventricular hypertrophy, atherosclerosis, and thrombosis (blood clots).

    ●Endocrine: Severe HPTA suppression (as discussed), testicular atrophy, infertility, gynecomastia (due to aromatization to estrogen), acne, accelerated male pattern baldness (androgenic).

    ●Psychological: Mood swings, irritability, aggression ("roid rage"), depression (especially post-cycle), potential dependency.

    ●Other: Edema (water retention), virilization in women (voice deepening, clitoromegaly, hair loss), accelerated growth plate closure in adolescents, insulin resistance, prostate enlargement.

Trade names	Methandienone; Methandrostenolone; Methandrolone; Perabol; Dehydromethyltestosterone; Methylboldenone;
CAS	72-63-9
Molar mass	300.442
MF	C20H28O2
Purity	Above 98%
Apprarance	White Crystalline Powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Dianabol (Methandrostenolone) powder represents the potent, unadulterated chemical core of a historically influential anabolic steroid. Its features – high oral bioavailability due to 17α-methylation, potent anabolic effects driven by AR binding, nitrogen retention, and rapid action – explain its historical notoriety. However, these come inextricably linked to severe and potentially irreversible health consequences, most notably hepatotoxicity, cardiovascular damage, and profound endocrine disruption requiring complex PCT for potential recovery.

 

Hot Tags: dianabol(methandrostenolone)steroids powder for bodybuilding cas:72-63-9, China dianabol(methandrostenolone)steroids powder for bodybuilding cas:72-63-9 manufacturers, suppliers, factory, Methyltestosterone, Nandrolone Decanoate, Stanozolol factory, Testosterone, Testosterone Acetate, Testosterone Phenylpropionate Enhances Muscle Mass